MedTrace Logo

Safety and Acceptability Study of a Non-Hormonal Ring

NCT03598088 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2022-06-08

Study results available
· View outcomes & findings →

Summary

This is a feasibility, multi-center, open-label, non-significant risk device study for a non-hormonal contraceptive ring.

Conditions

  • Contraception

Interventions

DEVICE

Ovaprene

non-hormonal contraceptive ring

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Daré Bioscience, Inc.

    lead INDUSTRY

Principal Investigators

  • Nadene A. Zack, MS · Sr Director, Clinical Operations

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-23
Primary Completion
2019-10-17
Completion
2019-11-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03598088 on ClinicalTrials.gov